Risk factors for early onset of diabetic nephropathy in pediatric type 1 diabetes

Journal of Pediatric Endocrinology and Metabolism

Volumn 23, Issue 12, 2010, Pages 1311-1320

  De Almeida Salgado, Patrícia Paz Cabral ^a   Silva, Ivani Novato ^a   Vieira, Érica Cristina ^a   Silva, Ana Cristina Simões E ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Blood glucose; Chronic renal insufficiency; Diabetes mellitus type 1; End stage renal disease; Proteinuria

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROALBUMINURIA; ONSET AGE; PROGNOSIS; PROTEINURIA; RISK FACTOR; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE OF ONSET; ALBUMINURIA; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; PREVALENCE; PROTEINURIA; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79955498642     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2010.205     Document Type: Article

References (36)

1. Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin N Am 2004; 88:1001-36. (Pubitemid 39090348)
2. Perkins BA, Krolewsky AS. Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress. Curr Diab Rep 2005; 5:455-63. (Pubitemid 43020013)
3. Gorman D, Sochett E, Daneman D. The natural history of microalbuminuria in adolescents with type 1 diabetes. J Pedia tr 1999; 134:333-7. (Pubitemid 30417643)
4. American Diabetes Association: Standards of Medical Care in Diabetes-2009. Diabetes Care 2009; 32 (Suppl 1):S13-S61.
5. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M. The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5- year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 2005; 54:2 164-71. (Pubitemid 40911280)
6. Dahlquist G, Stattin EL, Rudberg S. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients. N ephrol Dial Transplant 2001; 16:1382-6. (Pubitemid 32640592)
7. DCCT. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long- Term Complications in Insulin-Dependent Diabetes Mellitus. N Engl J Med 1993; 329:977-86.
8. Microalbuminuria Collaborative Study Group UK. Risk factors for development of microalbuminuria in insulin-dependent diabetic patients: A Cohort Study. BMJ 1993; 306:1235-9.
9. Coon rod BA, Ellis D, Becker DJ, et al. Predictors of microalbuminuria in individual with IDDM. Diabetes Care 1993; 16:1376-83.
10. Sinha RN, Patrick AW, Richardson L, Wallymahmed M, MacFarlane I A. A six-year follow-up study of smoking habits and microvascular complications in young adults with type 1 diabetes. Postgrad Med J 1997; 73:293-4. (Pubitemid 27248446)
11. The Microalbuminuria Collaborative Study Group. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. Diabet Med 1999; 16:918-25.
12. Muhlhauser I, Overmann H, Bender R, Jorgens V, Berger M. Predictors of mortality and end-stage diabetic complications in patients with type 1 diabetes mellitus on intensified insulin therapy. Diabet Med 2000; 17:727-34
13. Svensson M, Eriksson JW, Dahlquist G. Early glycemic control, age at onset, and development of microvascular complications in childhood-onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care 20 04; 27:955-62. (Pubitemid 38420221)
14. Schultz CJ, Konopelska T, Dalton RN, Carroll TA, Stratton I, Gale EA. Microalbuminuria prevalence varies with age, sex and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Diabetes Care 1999; 22:495-502. (Pubitemid 29106911)
15. Amin R, Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008; 36(7646): 697-701. (Pubitemid 351481211)
16. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Bloo d Pressure in Children and Adolescents. Pediatrics 2004;114:555-76.
17. Early Treatment Diabetic Retinopathy Study Research Group. Early treatment diabetic retinopathy study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;14: 499-502.
18. Tryggvason G, Indridason OS, Thorsson AV, Hreidarsson AB, Palsson R. Unchanged incidence of diabetic nephropathy in Type 1 diabetes: a nationwide study in Iceland. Diabet Med 2004; 22:182-7.
19. Svensson M, Sundkvist G, Arnqvist HJ, et al. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management. Results from de nationwide population-based diabetes incidence study in Sweden (DISS). Diabetes Care 2003; 26:2903-9. (Pubitemid 37205566)
20. Mortensen HB, Maginelle K, Norgoard K, Main K, Kastrup KW, Ibsen KK. A nation-wide crosssectio nal study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Danish Study Group of Diabetes in Childhood. Diabet Méd 1990; 7:887-97.
21. Salardi S, Cacciari E, Pascucci MG, et al. Microalbuminuria in diabetic children and adolescents: relationship with puberty and growth hormone. Acta Paediatr Scan 1990; 79: 437-443 (Pubitemid 20134098)
22. Sampaio E, Al meida HGG, Delfino VDA. Nephropathy and retinopathy in type 1 diabetics assisted by a universitary multiprofessional program [Nefropatia e retinopatia em diabéticos do tipo 1 de um programa de atendimento multiprofissional universitário]. Arq Bras Endocrinol Metab 2007; 51:410-8.
23. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003; 290:2159-67.
24. Drummond KN, Kramer M S, Suissa S, et al. Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy. Diabetes 2003; 52:1818-24. (Pubitemid 36792475)
25. Ceriello A, Esposito K, Piconi L, Ihnat M A, Thorpe J E, Testa R, Boemi M, and Giugliano D. Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients. Diabetes 2008; 57: 1349-54.
26. Harjutsalo V, Katoh S, Sarti C, Tajima N, Tuomilehto J. Population-based assesment of familial clustering of diabetic nephropathy in type 1 diabetes. Diabetes 2004; 53:2449-54. (Pubitemid 39145602)
27. Abraha A, Schultz C, Konopelska-Bahu T, et al. Glycaemic control and familial factors determine hyperlipidaemia in early childhood diabetes. Oxford Regional Prospective Study of Childhood Diabetes. Diabet Med 1999; 16:598-604.
28. Raile K, Galler A, Hofer S, et al. Diabetic Nephropathy in 27805 Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Care 2007; 30:2523-8.
29. Galler A, Muller G, Schinzel R, Kratzsch J, Kiess W, Munch G. Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA. Diabetes Care 2003; 26:2609-15. (Pubitemid 37052108)
30. Berenson GS, Srinivasan SR, Bao W, Newman 3rd WP, T racy RE, Wattigney WA Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338:1650-1656 (Pubitemid 28267909)
31. Amin R, Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008; 336(7646):677-8.
32. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. Diabetologia 1989; 32:219-26. (Pubitemid 19136363)
33. Rossing P, Hougaard P, Parving HH. Risk fac tors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 2002; 25:859-64. (Pubitemid 41094283)
34. Hovind P, Tarnow L, Rossing P, et al. Predictors of the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception Study. BMJ 2004; 328:1105-8. (Pubitemid 38608441)
35. Ayodele OE, Alebiosu CO, Salako BL. Diabetic nephropathy-a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc 2004; 96:1445-54. (Pubitemid 39482990)
36. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestr y in Brazilians. Proc Natl Acad Sci USA 2003; 100:177-182.